ILLUMINA INC (ILMN) Fundamental Analysis & Valuation

NASDAQ:ILMN • US4523271090

Current stock price

126.96 USD
+6.03 (+4.99%)
At close:
126.96 USD
0 (0%)
After Hours:

This ILMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ILMN Profitability Analysis

1.1 Basic Checks

  • In the past year ILMN was profitable.
  • ILMN had a positive operating cash flow in the past year.
  • In multiple years ILMN reported negative net income over the last 5 years.
  • Each year in the past 5 years ILMN had a positive operating cash flow.
ILMN Yearly Net Income VS EBIT VS OCF VS FCFILMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

1.2 Ratios

  • ILMN's Return On Assets of 12.79% is amongst the best of the industry. ILMN outperforms 96.49% of its industry peers.
  • With an excellent Return On Equity value of 31.22%, ILMN belongs to the best of the industry, outperforming 98.25% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 13.63%, ILMN belongs to the top of the industry, outperforming 92.98% of the companies in the same industry.
Industry RankSector Rank
ROA 12.79%
ROE 31.22%
ROIC 13.63%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ILMN Yearly ROA, ROE, ROICILMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

1.3 Margins

  • ILMN has a Profit Margin of 19.57%. This is amongst the best in the industry. ILMN outperforms 89.47% of its industry peers.
  • ILMN's Profit Margin has been stable in the last couple of years.
  • ILMN has a better Operating Margin (20.29%) than 85.96% of its industry peers.
  • In the last couple of years the Operating Margin of ILMN has grown nicely.
  • With an excellent Gross Margin value of 66.61%, ILMN belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
  • ILMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.29%
PM (TTM) 19.57%
GM 66.61%
OM growth 3Y36.82%
OM growth 5Y2.01%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
ILMN Yearly Profit, Operating, Gross MarginsILMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ILMN Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ILMN is creating some value.
  • ILMN has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ILMN has more shares outstanding
  • Compared to 1 year ago, ILMN has an improved debt to assets ratio.
ILMN Yearly Shares OutstandingILMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ILMN Yearly Total Debt VS Total AssetsILMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • ILMN has an Altman-Z score of 4.15. This indicates that ILMN is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 4.15, ILMN belongs to the best of the industry, outperforming 82.46% of the companies in the same industry.
  • ILMN has a debt to FCF ratio of 2.14. This is a good value and a sign of high solvency as ILMN would need 2.14 years to pay back of all of its debts.
  • The Debt to FCF ratio of ILMN (2.14) is better than 89.47% of its industry peers.
  • ILMN has a Debt/Equity ratio of 0.55. This is a neutral value indicating ILMN is somewhat dependend on debt financing.
  • ILMN has a worse Debt to Equity ratio (0.55) than 63.16% of its industry peers.
  • Although ILMN's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.14
Altman-Z 4.15
ROIC/WACC1.28
WACC10.61%
ILMN Yearly LT Debt VS Equity VS FCFILMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 2.08 indicates that ILMN has no problem at all paying its short term obligations.
  • The Current ratio of ILMN (2.08) is comparable to the rest of the industry.
  • ILMN has a Quick Ratio of 1.72. This is a normal value and indicates that ILMN is financially healthy and should not expect problems in meeting its short term obligations.
  • ILMN has a Quick ratio of 1.72. This is comparable to the rest of the industry: ILMN outperforms 42.11% of its industry peers.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.72
ILMN Yearly Current Assets VS Current LiabilitesILMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ILMN Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 97.96% over the past year.
  • Measured over the past 5 years, ILMN shows a small growth in Earnings Per Share. The EPS has been growing by 1.51% on average per year.
  • ILMN shows a decrease in Revenue. In the last year, the revenue decreased by -0.66%.
  • ILMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.04% yearly.
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%

3.2 Future

  • ILMN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.73% yearly.
  • Based on estimates for the next years, ILMN will show a small growth in Revenue. The Revenue will grow by 5.80% on average per year.
EPS Next Y7.91%
EPS Next 2Y10.93%
EPS Next 3Y11.63%
EPS Next 5Y11.73%
Revenue Next Year5.74%
Revenue Next 2Y5.67%
Revenue Next 3Y5.88%
Revenue Next 5Y5.8%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ILMN Yearly Revenue VS EstimatesILMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
ILMN Yearly EPS VS EstimatesILMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. ILMN Valuation Analysis

4.1 Price/Earnings Ratio

  • ILMN is valuated quite expensively with a Price/Earnings ratio of 26.18.
  • ILMN's Price/Earnings ratio is a bit cheaper when compared to the industry. ILMN is cheaper than 73.68% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.86, ILMN is valued at the same level.
  • The Price/Forward Earnings ratio is 24.26, which indicates a rather expensive current valuation of ILMN.
  • ILMN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ILMN is cheaper than 73.68% of the companies in the same industry.
  • ILMN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 37.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.18
Fwd PE 24.26
ILMN Price Earnings VS Forward Price EarningsILMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 77.19% of the companies in the same industry are more expensive than ILMN, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ILMN is valued cheaper than 82.46% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.85
EV/EBITDA 16.19
ILMN Per share dataILMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ILMN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.31
PEG (5Y)17.34
EPS Next 2Y10.93%
EPS Next 3Y11.63%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ILMN Dividend Analysis

5.1 Amount

  • ILMN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ILMN Fundamentals: All Metrics, Ratios and Statistics

ILLUMINA INC

NASDAQ:ILMN (4/13/2026, 4:04:10 PM)

After market: 126.96 0 (0%)

126.96

+6.03 (+4.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)04-30
Inst Owners106.54%
Inst Owner Change0.01%
Ins Owners0.18%
Ins Owner Change3.14%
Market Cap19.41B
Revenue(TTM)4.34B
Net Income(TTM)850.00M
Analysts73.57
Price Target139.02 (9.5%)
Short Float %4.74%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.14%
Min EPS beat(2)7.62%
Max EPS beat(2)12.65%
EPS beat(4)4
Avg EPS beat(4)9.22%
Min EPS beat(4)1.33%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)14.29%
EPS beat(12)10
Avg EPS beat(12)229.93%
EPS beat(16)13
Avg EPS beat(16)175.4%
Revenue beat(2)1
Avg Revenue beat(2)1.24%
Min Revenue beat(2)-0.28%
Max Revenue beat(2)2.75%
Revenue beat(4)1
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)2.75%
Revenue beat(8)3
Avg Revenue beat(8)-0.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.28%
Revenue beat(16)5
Avg Revenue beat(16)-0.88%
PT rev (1m)0.43%
PT rev (3m)10.09%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)-4.96%
EPS NY rev (1m)0.03%
EPS NY rev (3m)2.11%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.51%
Valuation
Industry RankSector Rank
PE 26.18
Fwd PE 24.26
P/S 4.47
P/FCF 20.85
P/OCF 17.99
P/B 7.13
P/tB 13.87
EV/EBITDA 16.19
EPS(TTM)4.85
EY3.82%
EPS(NY)5.23
Fwd EY4.12%
FCF(TTM)6.09
FCFY4.8%
OCF(TTM)7.06
OCFY5.56%
SpS28.4
BVpS17.81
TBVpS9.16
PEG (NY)3.31
PEG (5Y)17.34
Graham Number44.08
Profitability
Industry RankSector Rank
ROA 12.79%
ROE 31.22%
ROCE 17.41%
ROIC 13.63%
ROICexc 20.13%
ROICexgc 32.79%
OM 20.29%
PM (TTM) 19.57%
GM 66.61%
FCFM 21.44%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y1.94%
ROICexgc growth 5Y5.2%
ROICexc growth 3Y74.03%
ROICexc growth 5Y4.4%
OM growth 3Y36.82%
OM growth 5Y2.01%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.14
Debt/EBITDA 1.29
Cap/Depr 54.81%
Cap/Sales 3.41%
Interest Coverage 9.27
Cash Conversion 93.74%
Profit Quality 109.53%
Current Ratio 2.08
Quick Ratio 1.72
Altman-Z 4.15
F-Score8
WACC10.61%
ROIC/WACC1.28
Cap/Depr(3y)45.45%
Cap/Depr(5y)67.5%
Cap/Sales(3y)3.56%
Cap/Sales(5y)5.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
EPS Next Y7.91%
EPS Next 2Y10.93%
EPS Next 3Y11.63%
EPS Next 5Y11.73%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%
Revenue Next Year5.74%
Revenue Next 2Y5.67%
Revenue Next 3Y5.88%
Revenue Next 5Y5.8%
EBIT growth 1Y36.38%
EBIT growth 3Y34.38%
EBIT growth 5Y8.17%
EBIT Next Year32.66%
EBIT Next 3Y17.49%
EBIT Next 5Y16.57%
FCF growth 1Y31.31%
FCF growth 3YN/A
FCF growth 5Y0.88%
OCF growth 1Y28.91%
OCF growth 3Y40.15%
OCF growth 5Y-0.02%

ILLUMINA INC / ILMN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ILLUMINA INC?

ChartMill assigns a fundamental rating of 6 / 10 to ILMN.


Can you provide the valuation status for ILLUMINA INC?

ChartMill assigns a valuation rating of 5 / 10 to ILLUMINA INC (ILMN). This can be considered as Fairly Valued.


Can you provide the profitability details for ILLUMINA INC?

ILLUMINA INC (ILMN) has a profitability rating of 7 / 10.


What is the valuation of ILLUMINA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ILLUMINA INC (ILMN) is 26.18 and the Price/Book (PB) ratio is 7.13.


What is the earnings growth outlook for ILLUMINA INC?

The Earnings per Share (EPS) of ILLUMINA INC (ILMN) is expected to grow by 7.91% in the next year.